Pharmaceutical Losses: Thinking Through Pfizer and Merck

Includes: MRK, PFE
by: Richard Shaw
In light of yesterday’s tremendous announcement and loss by Pfizer, we are now thinking through Pfizer (NYSE:PFE) and Merck (NYSE:MRK).

As a backdrop to this thinking about operations and sales, we've put together a chart of some data that may be helpful to us, and perhaps to you.

While do not own either PFE or MRK, we have owned them several times in the past and probably will trade them again in the future. Our only current pharmaceutical position is Johnson & Johnson (NYSE:JNJ).

Stock Risk PFE MRK 1
stock rations pfe mrk 2